ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for CRSP

Stock NameCrispr Therapeutics AG
TickerCRSP(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCH0334081137
LEI506700O6IRRIQLT3W370

Show aggregate CRSP holdings

News associated with CRSP

Look Under The Hood: IYY Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-12 08:04:40
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 473 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
Mitsubishi UFJ Asset Management Co. Ltd. raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,725 shares of the company’s stock after buying an additional 473 […] - 2025-08-15 04:46:59
Sum Up The Parts: ESML Could Be Worth $50
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-12 08:44:07
Arkadios Wealth Advisors Has $382,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Arkadios Wealth Advisors decreased its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 7.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 11,238 shares of the company’s stock after selling 923 shares during the period. Arkadios Wealth Advisors’ holdings in CRISPR Therapeutics […] - 2025-08-06 06:46:57
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Purchased by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 21.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 68,058 shares of the company’s stock after acquiring an additional 12,025 shares during the period. Envestnet […] - 2025-07-29 04:09:03
Bank of New York Mellon Corp Boosts Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
Bank of New York Mellon Corp increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,702 shares of the company’s stock after acquiring an additional 1,133 shares during […] - 2025-07-28 04:22:49
Private Advisor Group LLC Increases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
Private Advisor Group LLC increased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 27.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,418 shares of the company’s stock after buying an additional 23,382 shares during the quarter. […] - 2025-07-23 06:23:04
3 Monster Stocks in the Making to Buy Right Now
Key PointsCRISPR Therapeutics is still in its early growth stage. - 2025-07-21 01:07:00
3 Monster Stocks to Hold for the Next 10 Years
Key PointsOnline video game platform Roblox is different from any other platform. - 2025-07-17 06:51:00
Allworth Financial LP Has $393,000 Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Allworth Financial LP lowered its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 23.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,560 shares of the company’s stock after selling 3,518 shares during the quarter. Allworth Financial LP’s holdings […] - 2025-07-15 06:16:47
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Lifted by Axxcess Wealth Management LLC
Axxcess Wealth Management LLC increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 10,309 shares of the company’s stock after acquiring an additional 393 shares during the period. Axxcess Wealth Management LLC’s holdings in CRISPR Therapeutics were worth […] - 2025-07-14 05:45:01
Traders Purchase Large Volume of Call Options on CRISPR Therapeutics (NASDAQ:CRSP)
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) was the recipient of some unusual options trading on Wednesday. Stock investors bought 10,886 call options on the company. This represents an increase of approximately 49% compared to the typical daily volume of 7,308 call options. CRISPR Therapeutics Trading Down 1.8% NASDAQ CRSP opened at $59.00 on […] - 2025-07-11 02:50:55
CRISPR Therapeutics (NASDAQ:CRSP) Given “Buy” Rating at Needham & Company LLC
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They presently have a $81.00 target price on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 34.82% from the stock’s […] - 2025-07-10 04:01:25
Vontobel Holding Ltd. Trims Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Vontobel Holding Ltd. lessened its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,741 shares of the company’s stock after selling 2,327 shares during the quarter. Vontobel Holding Ltd.’s holdings […] - 2025-07-08 05:21:04
Spire Wealth Management Has $57,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Spire Wealth Management reduced its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,670 shares of the company’s stock after selling 300 shares during the period. Spire Wealth Management’s […] - 2025-07-02 04:46:55
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $69.53 Average Target Price from Analysts
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have earned a consensus recommendation of “Hold” from the seventeen brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and nine have issued a buy recommendation on the company. […] - 2025-06-24 02:54:46
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Bought by Farther Finance Advisors LLC
Farther Finance Advisors LLC lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 46.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,626 shares of the company’s stock after purchasing an additional 1,792 […] - 2025-06-20 04:29:03
Analysts Expect JHSC To Hit $45
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-10 08:53:42
California State Teachers Retirement System Sells 689 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
California State Teachers Retirement System lowered its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,742 shares of the company’s stock after selling 689 shares during the period. California State […] - 2025-06-06 05:06:55
The Best Stocks to Invest $1,000 in Right Now
Are you just as afraid of a market pullback right now as you are of missing out on upside? If so, you're not alone. This is a confusing environment for investors. Major names like Nvidia and Home Depot are sending mixed messages, while the market itself seems to be waiting for mo - 2025-06-03 05:30:00
Two Sigma Advisers LP Increases Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
Two Sigma Advisers LP lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 50.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 84,800 shares of the company’s stock after acquiring an additional 28,400 shares during the period. Two Sigma Advisers LP’s holdings in CRISPR Therapeutics were worth $3,338,000 as of […] - 2025-05-27 05:30:57
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of “Moderate Buy” by Analysts
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eighteen ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and ten have assigned a buy recommendation […] - 2025-05-27 03:06:46
Ameriprise Financial Inc. Has $8.07 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
Ameriprise Financial Inc. lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 205,173 shares of the company’s stock after acquiring an additional 18,412 shares during the period. Ameriprise Financial Inc.’s holdings in CRISPR Therapeutics were worth $8,072,000 as of its most recent […] - 2025-05-22 04:35:07
5 Monster Stocks to Hold for the Next 10 Years
The professionals who manage Wall Street funds and cater to wealthy investors live and die by their quarterly performance. However, the individual investor can win the long game by focusing on what will matter the most years into the future. - 2025-05-20 05:30:00
BNP Paribas Financial Markets Has $3.27 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
BNP Paribas Financial Markets decreased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 82,994 shares of the company’s stock after selling 4,962 shares during the quarter. BNP […] - 2025-05-16 05:08:54
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Decreased by Mercer Global Advisors Inc. ADV
Mercer Global Advisors Inc. ADV lessened its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 13.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,980 shares of the company’s stock after selling 1,598 shares during […] - 2025-05-15 05:10:56
Barclays Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $42.00
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its price target lowered by Barclays from $56.00 to $42.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities analysts have also recently commented on the stock. Truist Financial boosted their price […] - 2025-05-12 05:46:49
3 Monster Stocks to Hold for the Next 10 Years
The best investments are often stocks of companies offering goods and services that are perpetually in demand. Think entertainment, healthcare, or more recently, some consumer technologies. Many of these stocks can be bought and held forever, since they dish out reasonably predic - 2025-05-10 06:12:00
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Growth stocks have been rallying in recent weeks, and that's usually great news for Cathie Wood. The founder, CEO, and stock-picking ace of the Ark Invest family of exchange-traded funds (ETFs) has momentum on her side. Her largest fund has soared nearly 30% since bottoming out l - 2025-05-08 12:22:00
Dimensional Fund Advisors LP Has $37.28 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
Dimensional Fund Advisors LP boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 14.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 947,301 shares of the company’s stock after purchasing an additional 122,695 shares during the quarter. Dimensional […] - 2025-05-05 05:20:52

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CRSP holdings

DateNumber of CRSP Shares HeldBase Market Value of CRSP SharesLocal Market Value of CRSP SharesChange in CRSP Shares HeldChange in CRSP Base ValueCurrent Price per CRSP Share HeldPrevious Price per CRSP Share Held
2025-12-11 (Thursday)24,576USD 1,427,620USD 1,427,620
2025-12-10 (Wednesday)24,576USD 1,415,332CRSP holding increased by 13517USD 1,415,3320USD 13,517 USD 57.59 USD 57.04
2025-12-09 (Tuesday)24,576USD 1,401,815CRSP holding decreased by -7864USD 1,401,8150USD -7,864 USD 57.04 USD 57.36
2025-12-08 (Monday)24,576USD 1,409,679CRSP holding increased by 11796USD 1,409,6790USD 11,796 USD 57.36 USD 56.88
2025-12-05 (Friday)24,576USD 1,397,883CRSP holding decreased by -31949USD 1,397,8830USD -31,949 USD 56.88 USD 58.18
2025-12-04 (Thursday)24,576USD 1,429,832CRSP holding increased by 53822USD 1,429,8320USD 53,822 USD 58.18 USD 55.99
2025-12-03 (Wednesday)24,576CRSP holding decreased by -430USD 1,376,010CRSP holding increased by 86201USD 1,376,010-430USD 86,201 USD 55.99 USD 51.58
2025-12-02 (Tuesday)25,006CRSP holding increased by 172USD 1,289,809CRSP holding decreased by -5781USD 1,289,809172USD -5,781 USD 51.58 USD 52.17
2025-12-01 (Monday)24,834USD 1,295,590CRSP holding decreased by -32284USD 1,295,5900USD -32,284 USD 52.17 USD 53.47
2025-11-28 (Friday)24,834USD 1,327,874CRSP holding increased by 4222USD 1,327,8740USD 4,222 USD 53.47 USD 53.3
2025-11-27 (Thursday)24,834USD 1,323,652USD 1,323,6520USD 0 USD 53.3 USD 53.3
2025-11-26 (Wednesday)24,834USD 1,323,652CRSP holding decreased by -6705USD 1,323,6520USD -6,705 USD 53.3 USD 53.57
2025-11-25 (Tuesday)24,834CRSP holding decreased by -258USD 1,330,357CRSP holding increased by 44392USD 1,330,357-258USD 44,392 USD 53.57 USD 51.25
2025-11-24 (Monday)25,092CRSP holding increased by 1747USD 1,285,965CRSP holding increased by 113346USD 1,285,9651,747USD 113,346 USD 51.25 USD 50.23
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRSP by Blackrock for IE00B3VWM098

Show aggregate share trades of CRSP

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-43056.01051.160 51.645USD -22,207 47.56 Loss of -1,756 on sale
2025-12-02BUY17253.03051.244 51.423USD 8,845 47.54
2025-11-25SELL-25853.89049.970 50.362USD -12,993 47.41 Loss of -763 on sale
2025-11-24BUY1,74751.50049.350 49.565USD 86,590 47.39
2025-11-17SELL-86955.76051.220 51.674USD -44,905 47.28 Loss of -3,823 on sale
2025-11-12SELL-7955.69052.050 52.414USD -4,141 47.20 Loss of -412 on sale
2025-11-06SELL-7958.75054.570 54.988USD -4,344 47.03 Loss of -628 on sale
2025-11-05SELL-79057.23054.910 55.142USD -43,562 46.98 Loss of -6,447 on sale
2025-11-04SELL-16060.64056.000 56.464USD -9,034 46.93 Loss of -1,525 on sale
2025-11-03SELL-16064.73660.530 60.951USD -9,752 46.85 Loss of -2,256 on sale
2025-10-28BUY24064.17065.710 65.556USD 15,733 46.50
2025-10-24SELL-8067.61068.710 68.600USD -5,488 46.28 Loss of -1,785 on sale
2025-10-15BUY47471.82073.090 72.963USD 34,584 45.34
2025-10-02BUY7972.82072.950 72.937USD 5,762 45.06
2025-09-30BUY15864.81066.290 66.142USD 10,450 44.82
2025-08-21SELL-4952.82053.045 53.022USD -2,598 44.38 Loss of -424 on sale
2025-07-31BUY14756.26058.500 58.276USD 8,567 44.25
2025-06-30SELL-9848.64051.520 51.232USD -5,021 42.56 Loss of -850 on sale
2025-06-25SELL-4947.66048.480 48.398USD -2,372 42.46 Loss of -291 on sale
2025-06-20SELL-9844.25045.140 45.051USD -4,415 42.39 Loss of -260 on sale
2025-05-30BUY4,99236.29036.950 36.884USD 184,125 42.58
2025-05-23BUY3136.86037.200 37.166USD 1,152 42.81
2025-05-19SELL-3138.68039.000 38.968USD -1,208 42.97 Profit of 124 on sale
2025-05-15SELL-9336.31036.360 36.355USD -3,381 43.07 Profit of 624 on sale
2025-05-12SELL-3137.59038.020 37.977USD -1,177 43.24 Profit of 163 on sale
2025-05-09SELL-3135.62037.340 37.168USD -1,152 43.31 Profit of 190 on sale
2025-04-30SELL-3138.67038.880 38.859USD -1,205 43.76 Profit of 152 on sale
2025-04-24SELL-6239.11039.350 39.326USD -2,438 43.99 Profit of 289 on sale
2025-04-17SELL-3137.77038.215 38.171USD -1,183 44.30 Profit of 190 on sale
2025-04-15SELL-9338.95039.890 39.796USD -3,701 44.43 Profit of 431 on sale
2025-04-14SELL-9338.81040.129 39.997USD -3,720 44.49 Profit of 418 on sale
2025-04-09SELL-12434.89035.060 35.043USD -4,345 44.77 Profit of 1,206 on sale
2025-04-07SELL-21732.38034.216 34.032USD -7,385 45.07 Profit of 2,396 on sale
2025-04-04SELL-31032.65032.990 32.956USD -10,216 45.22 Profit of 3,802 on sale
2025-03-31BUY3134.03035.750 35.578USD 1,103 45.64
2025-03-19SELL-6241.94042.750 42.669USD -2,645 46.22 Profit of 220 on sale
2025-03-14SELL-18642.12043.480 43.344USD -8,062 46.40 Profit of 568 on sale
2025-03-13SELL-6241.99044.390 44.150USD -2,737 46.46 Profit of 143 on sale
2025-03-12SELL-1,05443.49043.940 43.895USD -46,265 46.51 Profit of 2,752 on sale
2025-03-07SELL-6245.53045.790 45.764USD -2,837 46.63 Profit of 54 on sale
2025-03-06SELL-9343.31043.740 43.697USD -4,064 46.68 Profit of 278 on sale
2025-03-03SELL-3142.29045.200 44.909USD -1,392 46.85 Profit of 60 on sale
2025-02-28SELL-18643.92044.510 44.451USD -8,268 46.90 Profit of 455 on sale
2025-02-26SELL-3144.40046.000 45.840USD -1,421 47.00 Profit of 36 on sale
2025-02-25SELL-9344.51046.670 46.454USD -4,320 47.04 Profit of 54 on sale
2025-02-18BUY15552.22055.300 54.992USD 8,524 46.76
2025-02-13BUY3143.49044.140 44.075USD 1,366 46.70
2025-02-12BUY3143.30044.200 44.110USD 1,367 46.77
2025-02-11BUY9339.62039.720 39.710USD 3,693 46.92
2025-02-06BUY27940.61042.880 42.653USD 11,900 47.39
2025-01-27BUY3141.85042.860 42.759USD 1,326 48.69
2024-12-30BUY15538.65039.670 39.568USD 6,133 49.50
2024-12-06BUY12452.33052.390 52.384USD 6,496 49.43
2024-12-05BUY3149.51051.280 51.103USD 1,584 49.42
2024-12-04BUY15551.14052.310 52.193USD 8,090 49.36
2024-11-29BUY15551.17051.670 51.620USD 8,001 48.98
2024-11-27BUY12450.84050.970 50.957USD 6,319 48.82
2024-11-26BUY3149.31050.630 50.498USD 1,565 48.80
2024-11-25SELL-22,93850.40051.728 51.595USD -1,183,491 48.72 Loss of -65,875 on sale
2024-11-21BUY50546.29047.210 47.118USD 23,795 48.90
2024-11-20BUY30347.26047.910 47.845USD 14,497 48.99
2024-11-18BUY1,21247.30048.280 48.182USD 58,397 49.22
2024-11-12BUY80850.73053.990 53.664USD 43,361 49.12
2024-11-08BUY50551.62052.520 52.430USD 26,477 48.94
2024-11-07BUY1,51551.88053.260 53.122USD 80,480 48.71
2024-11-06BUY20250.72051.880 51.764USD 10,456 48.54
2024-10-31BUY10146.39047.990 47.830USD 4,831 48.05
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRSP

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19953,1154,3291,561,11361.1%
2025-09-18785,5858,0691,220,45764.4%
2025-09-17969,1214,9531,279,72475.7%
2025-09-16717,6969,1171,297,12555.3%
2025-09-15563,632479919,63661.3%
2025-09-12474,757434740,27664.1%
2025-09-11514,5242,730952,48454.0%
2025-09-10332,259613508,09265.4%
2025-09-09499,735309750,77466.6%
2025-09-08359,91019,558639,19756.3%
2025-09-05505,8603,4281,468,73234.4%
2025-09-04422,3912821,377,45130.7%
2025-09-03409,382185711,84457.5%
2025-09-02441,840754719,66961.4%
2025-08-29356,0631,032642,32555.4%
2025-08-28384,5934,175619,95962.0%
2025-08-27474,604413707,40967.1%
2025-08-26337,8011,235504,21067.0%
2025-08-25341,566592535,90963.7%
2025-08-22432,3111,060750,30757.6%
2025-08-21276,384525494,43955.9%
2025-08-20481,0352,447863,22655.7%
2025-08-19927,2488,1941,463,44963.4%
2025-08-18615,0979,049934,75965.8%
2025-08-15954,88210,7021,464,72165.2%
2025-08-141,089,3921,0361,635,55366.6%
2025-08-131,486,6797,8272,362,62762.9%
2025-08-12691,84570906,26476.3%
2025-08-11532,8841,847848,36362.8%
2025-08-08465,4267,018715,83465.0%
2025-08-07619,86741,404892,22269.5%
2025-08-06732,61952,4161,122,40965.3%
2025-08-051,326,11768,3261,979,71667.0%
2025-08-04954,1332,8201,308,60572.9%
2025-08-01942,9501,5531,336,17470.6%
2025-07-31761,4542,9451,160,13565.6%
2025-07-30798,1897,6891,224,48365.2%
2025-07-291,040,5228,0251,845,44256.4%
2025-07-28381,2151,024710,36953.7%
2025-07-25712,0351,8071,285,84055.4%
2025-07-24895,7845,5051,297,74669.0%
2025-07-231,105,98171,3881,837,17860.2%
2025-07-221,078,8158,8581,753,95261.5%
2025-07-211,982,72046,3673,377,74658.7%
2025-07-182,862,09113,8775,362,03053.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy